Skip to main content
SpringerLink
Log in

Aberrant non-canonical WNT pathway as key-driver of high-grade serous ovarian cancer development

  • Commentary
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics. CA Cancer J Clin 69(1):7–34

    Article  Google Scholar 

  2. Prat J (2012) Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 460(3):237–249. https://doi.org/10.1007/s00428-012-1203-5

  3. Arend RC, Londono-Joshi AI, Straughn JM Jr, Buchsbaum DJ (2013) The Wnt/beta-catenin pathway in ovarian cancer: a review. Gynecol Oncol 131:772–779

    Article  CAS  Google Scholar 

  4. Bovolenta P, Rodriguez J, Esteve P (2006) nFrizzled/RIK mediated signalling in axon guidance. Development 133:4399–4408

    Article  CAS  Google Scholar 

  5. Veeman MT, Axelrod JD, Moon RT (2003) A second canon. Functions and mechanisms of beta-catenin independent WNT signalling. Dev Cell 5:367–377

    Article  CAS  Google Scholar 

  6. Pannone G, Bufo P, Santoro A, Franco R, Aquino G, Longo F, Botti G, Serpico R, Cafarelli B, Abbruzzese A, Caraglia M, Papagerakis S, Lo Muzio L (2010) WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep 24:1035–1041

    CAS  PubMed  Google Scholar 

  7. Polakis P (2007) The many ways of WNT in cancer. Curr Opin Gen Develop 17:45–51

    Article  CAS  Google Scholar 

  8. Teeuwssen M, Fodde R (2019) Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance. Clin Med 8:1658. https://doi.org/10.3390/jcm8101658

    Article  CAS  Google Scholar 

  9. Chen MW, Yang ST, Chien MH, Hua KT, Wu CJ, Hsiao SM, Lin H, Hsiao M, Su JL, Wei LH (2017) The STAT3- miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. Cancer Res 77(8):1955–1967

    Article  CAS  Google Scholar 

  10. Chehover M, Reich R, Davidson B (2020) Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma. Virchows Arch. https://doi.org/10.1007/s00428-019-02737-z

  11. Raghavan S, Mehta P, Xie Y, Lei YL, Mehta G (2019) Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments. J Immunother Cancer 7(1):190

    Article  Google Scholar 

  12. Moore KN, Gunderson CC, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger RA et al (2019) A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol 154(2):294–301

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Unità di Gineco-patologia e Patologia Mammaria, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go Francesco Vito, 1, 00168, Rome, Italy

    Gian Franco Zannoni, Giuseppe Angelico & Angela Santoro

  2. Istituto di Anatomia Patologica, Università Cattolica del Sacro Cuore, Rome, Italy

    Gian Franco Zannoni

Authors
  1. Gian Franco Zannoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Angelico
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela Santoro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gian Franco Zannoni.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

See related article, https://doi.org/10.1007/s00428-019-02737-z

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zannoni, G.F., Angelico, G. & Santoro, A. Aberrant non-canonical WNT pathway as key-driver of high-grade serous ovarian cancer development. Virchows Arch 477, 321–322 (2020). https://doi.org/10.1007/s00428-020-02760-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-020-02760-5

Search

Navigation